Dianthus Therapeutics DNTH
NASDAQ DNTH
$78.10 -0.65 (-0.83%)
At close: Oct 21, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Other Operating Expenses (2023 - 2024)

Updated

Dianthus Therapeutics' Other Operating Expenses came in at -$4.8 million for Q4 2024.

Analysis

Dianthus Therapeutics (DNTH) Other Operating Expenses (2023 - 2024) Analysis & Trends

  • The Q4 2024 figure represents the highest quarterly Other Operating Expenses since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Dianthus Therapeutics 2.95 Bn 2.90 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.80 Mn
Jun 30, 2023 -1.92 Mn
Mar 31, 2023 -18.00 Mn
API Access

Dianthus Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DNTH&period=max&api_key=YOUR_API_KEY